Schedule 13G ownership disclosure
RIGEL PHARMACEUTICALS INC
Security class unavailable · CUSIP: 766559603
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,198,571
- Percent of class
- 6.6300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-21-000300
- Form type
- SC 13G
- Filer
- RIGEL PHARMACEUTICALS INC
- CIK
- CIK 1034842
- Filed
- Feb 04, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership